| Patricia Vann, PHD, LPC | |
|
7 Rosemar Cir, Parkersburg, WV 26104-1203 | |
| (304) 422-7999 | |
| (681) 661-0257 |
| Full Name | Patricia Vann |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 7 Rosemar Cir, Parkersburg, West Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245724350 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 462 (West Virginia) | Secondary |
| 101YP2500X | Counselor - Professional | 2518 (West Virginia) | Primary |
| Entity Name | Rise Up Mental Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831854223 PECOS PAC ID: 3577953629 Enrollment ID: O20211202003017 |
News Archive
Consumer Reports, the world's largest and most trusted nonprofit consumer organization, today announced its commitment to help wipe out antibiotic-resistant bacteria or "superbugs." Infections related to the use of antibiotics sicken about 2.25 million Americans each year and kill 37,000, according to the Centers for Disease Control and Prevention.
Increased NEK2 gene expression linked to increased drug resistance, faster cancer growth, and poorer patient outcome - The finding may improved diagnostic and prognostic tools for cancer care and could lead to improved cancer therapies
Scientists have mapped out the genes that keep our cells alive, creating a long-awaited foothold for understanding how our genome works and which genes are crucial in disease like cancer.
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that it intends to offer, subject to market and other conditions, 8,500,000 shares of its common stock in an underwritten public offering. ImmunoGen expects to grant the underwriters a thirty (30) day option to purchase up to 1,275,000 additional shares to cover over-allotments, if any.
Nova Southeastern University will create the College of Nursing on Jan. 1., 2012. Formally a part of NSU's College of Allied Health and Nursing, the new college has emerged because of the nursing program's growth and success over the last five years.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patricia Vann, PHD, LPC 7 Rosemar Cir, Parkersburg, WV 26104-1203 Ph: (304) 422-7999 | Patricia Vann, PHD, LPC 7 Rosemar Cir, Parkersburg, WV 26104-1203 Ph: (304) 422-7999 |
News Archive
Consumer Reports, the world's largest and most trusted nonprofit consumer organization, today announced its commitment to help wipe out antibiotic-resistant bacteria or "superbugs." Infections related to the use of antibiotics sicken about 2.25 million Americans each year and kill 37,000, according to the Centers for Disease Control and Prevention.
Increased NEK2 gene expression linked to increased drug resistance, faster cancer growth, and poorer patient outcome - The finding may improved diagnostic and prognostic tools for cancer care and could lead to improved cancer therapies
Scientists have mapped out the genes that keep our cells alive, creating a long-awaited foothold for understanding how our genome works and which genes are crucial in disease like cancer.
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that it intends to offer, subject to market and other conditions, 8,500,000 shares of its common stock in an underwritten public offering. ImmunoGen expects to grant the underwriters a thirty (30) day option to purchase up to 1,275,000 additional shares to cover over-allotments, if any.
Nova Southeastern University will create the College of Nursing on Jan. 1., 2012. Formally a part of NSU's College of Allied Health and Nursing, the new college has emerged because of the nursing program's growth and success over the last five years.
› Verified 6 days ago